PURACAP PHARMACEUTICAL Trademark

Trademark Overview


On Monday, June 14, 2010, a trademark application was filed for PURACAP PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the PURACAP PHARMACEUTICAL trademark a serial number of 85061827. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 16, 2022. This trademark is owned by PuraCap Pharmaceutical LLC. The PURACAP PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
puracap pharmaceutical

General Information


Serial Number85061827
Word MarkPURACAP PHARMACEUTICAL
Filing DateMonday, June 14, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 16, 2022
Registration Number4109588
Registration DateTuesday, March 6, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 23, 2010

Trademark Statements


Description of MarkThe mark consists of the word "PuraCap" over the word "PHARMACEUTICAL" and surrounded by an elliptical shape with its lower right-quadrant omitted.
Goods and Servicespharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICAL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateMonday, January 9, 2012
First Use In Commerce DateMonday, January 9, 2012

Trademark Owner History


Party NamePuraCap Pharmaceutical LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSouth Plainfield, NJ 07080

Party NamePuraCap Pharmaceutical LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouth Plainfield, NJ 07080

Party NamePuraCap Pharmaceutical LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouth Plainfield, NJ 07080

Trademark Events


Event DateEvent Description
Friday, September 16, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, March 6, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 25, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 25, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 25, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 5, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, March 6, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 6, 2012REGISTERED-PRINCIPAL REGISTER
Friday, February 3, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 2, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, February 1, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 31, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 2012USE AMENDMENT FILED
Friday, January 13, 2012TEAS STATEMENT OF USE RECEIVED
Monday, October 31, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 19, 2011TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2011SOU EXTENSION 1 GRANTED
Thursday, July 14, 2011SOU EXTENSION 1 FILED
Friday, July 22, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 14, 2011TEAS EXTENSION RECEIVED
Tuesday, January 18, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 23, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2010PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 20, 2010ASSIGNED TO LIE
Tuesday, October 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, September 29, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 29, 2010EXAMINERS AMENDMENT E-MAILED
Wednesday, September 29, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, September 24, 2010PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, September 24, 2010TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 22, 2010ASSIGNED TO EXAMINER
Friday, June 18, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, June 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 17, 2010NEW APPLICATION ENTERED IN TRAM